Eastman Chemical (EMN) Cost of Revenue (2009 - 2026)

Eastman Chemical (EMN) has reported Cost of Revenue for 18 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 9.66% year-over-year to $2.0 billion; the trailing twelve-month figure through Jun 2026 stood at $7.1 billion (up 0.69% YoY), and the FY2025 full-year result was $6.9 billion, down 2.59% from the prior year.
• Cost of Revenue improved to $2.0 billion in Q2 2026 per EMN's latest filing, from $1.7 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.2 billion in Q3 2022 and bottomed at $1.6 billion in Q4 2025.
• Historically, Cost of Revenue has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue gained 19.49% in 2022, then dropped 17.76% in 2023.
• Over 5 years, Cost of Revenue stood at $2.0 billion in 2022, then decreased by 12.72% to $1.7 billion in 2023, then retreated by 2.98% to $1.7 billion in 2024, then slipped by 3.31% to $1.6 billion in 2025, then advanced by 19.45% to $2.0 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.0 billion, $1.7 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.